Targovax
Replimune
Genelux Corporation
Candel Therapeutics
DNAtrix
SillaJen
Treovir
Lokon Pharma AB
Istari Oncology
CG Oncology
Amgen
Daiichio Sankyo
Published | Pages | Publisher | Report code |
---|---|---|---|
Sep 2022 | 239 | DelveInsight | ASDR-609111 |
Targovax
Replimune
Genelux Corporation
Candel Therapeutics
DNAtrix
SillaJen
Treovir
Lokon Pharma AB
Istari Oncology
CG Oncology
Amgen
Daiichio Sankyo